Biomedical informatics at the University of Massachusetts Medical School (UMMS) provides support for the conduct, administration, analysis, and dissemination of clinical and translational research from bench to clinic to populations.
Biostatistics, Epidemiology, and Research Design
High quality translational research requires expertise in the design, analysis, and conduct of observational studies, randomized controlled trials, quasi-experimental designs, and complex laboratory studies. A key element of the BERD component is the Department of Quantitative Health Sciences, which fosters collaboration among existing clinical and basic science entities with the goal of shortening the time between laboratory breakthroughs and clinical applications.
Advanced Therapeutics Cluster
The mission of the ATC is to apply the knowledge flowing from the latest biomedical discoveries to develop new ways to treat disease and then drive those therapies into clinical trials.
MassBiologics' mission is to discover and develop products that will significantly improve public health. This includes products for smaller patient populations due to limited incidence of disease (orphan products), uncertain markets as new challenges to public health arise, or products for developing nations with limited resources and unique needs.
Massachusetts Medical Device Development (M2D2) Center
The Massachusetts Medical Device Development Center (M2D2) is a lifeline for the state’s smaller medical device companies, offering inventors and executives easy, affordable, and coordinated access to world-class researchers and resources at the Lowell and Worcester campuses of the University of Massachusetts.